Ahiflower oil gets novel food approval for Brazil
ANVISA granted “safety and efficacy as a bioactive substance” premarket approval of Ahiflower in August, the culmination of a multiyear review by ANVISA of Ahiflower’s safety and efficacy substantiation, which is required for foods or bioactive substances claims in Brazil.
Ahiflower oil from Buglossoides arvensis reportedly offers the highest levels of non-GM omega-3 essential fatty acids among commercially available dietary plant oils. Ahiflower oil combines alpha-linolenic acid (ALA, C18:3 n-3) and high levels of stearidonic acid (SDA, 18:4 n-3). SDA converts to eicosapentaenoic acid (EPA, C20:5 n-3) at ratio of 30% to 35%, and direct consumption of SDA is far more efficient than consuming large amounts of ALA. The oil also contains omega-6 gamma linolenic acid (GLA).
“Many people around the world are seeking to boost their health and fitness through more mindful and sustainable plant-based ingredients,” said Greg Cumberford, VP Science & Regulatory. “They are also wanting to instill the same values in their kids through convenient, healthy, food-friendly formats like gummies, snack foods, and ‘drinkable meal’ options. The new ANVISA approval means that Brazilian families will join North American and European families in getting Ahiflower oil’s complete and balanced omega benefits.”
Natures Crops’ Brazilian partner Ayalla also welcomed the announcement. “Ayalla is extremely excited to have achieved the approval for Ahiflower oil with ANVISA with distinction,” said Sandra Ayalla de Anselmo, Ayalla’s Business Development Director. “This opens up great opportunities to bring sustainable, complete & balanced plant-based omegas to Brazilian consumers and make a positive impact on human nutrition in our country.”
The Ahiflower crop is regeneratively grown by independently qualified farmers to ensure purity and traceability. Natures Crops’ recent B-Corp certification affirms Ahiflower oil’s eco-friendly status.
